# FDA Inspection 1013344 - Novo Nordisk Inc. - April 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/1d5c8257-f349-440a-9ebf-72db3b05a4f4
Source feed: FDA_Inspections

> FDA Inspection 1013344 for Novo Nordisk Inc. on April 13, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1013344
- Company Name: Novo Nordisk Inc.
- Inspection Date: 2017-04-13
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1255957 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/38330e07-dc29-4eb1-b194-25515448e660)
- [FDA Inspection 1255957 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/db492566-9b2c-498b-81f8-e95e929b2d49)
- [FDA Inspection 1255957 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/b68c3a3c-5d39-4d5e-b050-802a21bd26f0)
- [FDA Inspection 1194065 - 2022-12-21](https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/0dcc2982-f697-4dd2-98e6-769e21d4f06a)
- [FDA Inspection 983531 - 2016-07-22](https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/3f1b4ae6-1974-49b0-b186-49cb78cbf28b)

Company: https://www.keypedia.com/companies/novo-nordisk-inc/920bb4ea-9450-45a6-bcd7-9f85c2f2bbad

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c